Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes
Abstract Coronavirus disease 2019 (COVID-19) is associated with systemic inflammation. A wide range of adipokines activities suggests they influence pathogenesis and infection course. The aim was to assess concentrations of chemerin, omentin, and vaspin among COVID-19 patients with an emphasis on ad...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ab7ee6424fed4bea89e7d91ef4bfec76 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ab7ee6424fed4bea89e7d91ef4bfec76 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ab7ee6424fed4bea89e7d91ef4bfec762021-11-08T10:49:14ZAnti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes10.1038/s41598-021-00928-w2045-2322https://doaj.org/article/ab7ee6424fed4bea89e7d91ef4bfec762021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-00928-whttps://doaj.org/toc/2045-2322Abstract Coronavirus disease 2019 (COVID-19) is associated with systemic inflammation. A wide range of adipokines activities suggests they influence pathogenesis and infection course. The aim was to assess concentrations of chemerin, omentin, and vaspin among COVID-19 patients with an emphasis on adipokines relationship with COVID-19 severity, concomitant metabolic abnormalities and liver dysfunction. Serum chemerin, omentin and vaspin concentrations were measured in serum collected from 70 COVID-19 patients at the moment of admission to hospital, before any treatment was applied and 20 healthy controls. Serum chemerin and omentin concentrations were significantly decreased in COVID-19 patients compared to healthy volunteers (271.0 vs. 373.0 ng/ml; p < 0.001 and 482.1 vs. 814.3 ng/ml; p = 0.01, respectively). There were no correlations of analyzed adipokines with COVID-19 severity based on the presence of pneumonia, dyspnea, or necessity of Intensive Care Unit hospitalization (ICU). Liver test abnormalities did not influence adipokines levels. Elevated GGT activity was associated with ICU admission, presence of pneumonia and elevated concentrations of CRP, ferritin and interleukin 6. Chemerin and omentin depletion in COVID-19 patients suggests that this adipokines deficiency play influential role in disease pathogenesis. However, there was no relationship between lower adipokines level and frequency of COVID-19 symptoms as well as disease severity. The only predictive factor which could predispose to a more severe COVID-19 course, including the presence of pneumonia and ICU hospitalization, was GGT activity.Michał KuklaTomasz MenżykMarcin DembińskiMarek WiniarskiAleksander GarlickiMonika Bociąga-JasikMagdalena SkoniecznaDorota HudyBarbara MaziarzBeata Kusnierz-CabalaLubomir SkladanyIvica GrgurevicMałgorzata Wójcik-BugajskaTomasz GrodzickiDominika StygarTomasz RogulaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Michał Kukla Tomasz Menżyk Marcin Dembiński Marek Winiarski Aleksander Garlicki Monika Bociąga-Jasik Magdalena Skonieczna Dorota Hudy Barbara Maziarz Beata Kusnierz-Cabala Lubomir Skladany Ivica Grgurevic Małgorzata Wójcik-Bugajska Tomasz Grodzicki Dominika Stygar Tomasz Rogula Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes |
description |
Abstract Coronavirus disease 2019 (COVID-19) is associated with systemic inflammation. A wide range of adipokines activities suggests they influence pathogenesis and infection course. The aim was to assess concentrations of chemerin, omentin, and vaspin among COVID-19 patients with an emphasis on adipokines relationship with COVID-19 severity, concomitant metabolic abnormalities and liver dysfunction. Serum chemerin, omentin and vaspin concentrations were measured in serum collected from 70 COVID-19 patients at the moment of admission to hospital, before any treatment was applied and 20 healthy controls. Serum chemerin and omentin concentrations were significantly decreased in COVID-19 patients compared to healthy volunteers (271.0 vs. 373.0 ng/ml; p < 0.001 and 482.1 vs. 814.3 ng/ml; p = 0.01, respectively). There were no correlations of analyzed adipokines with COVID-19 severity based on the presence of pneumonia, dyspnea, or necessity of Intensive Care Unit hospitalization (ICU). Liver test abnormalities did not influence adipokines levels. Elevated GGT activity was associated with ICU admission, presence of pneumonia and elevated concentrations of CRP, ferritin and interleukin 6. Chemerin and omentin depletion in COVID-19 patients suggests that this adipokines deficiency play influential role in disease pathogenesis. However, there was no relationship between lower adipokines level and frequency of COVID-19 symptoms as well as disease severity. The only predictive factor which could predispose to a more severe COVID-19 course, including the presence of pneumonia and ICU hospitalization, was GGT activity. |
format |
article |
author |
Michał Kukla Tomasz Menżyk Marcin Dembiński Marek Winiarski Aleksander Garlicki Monika Bociąga-Jasik Magdalena Skonieczna Dorota Hudy Barbara Maziarz Beata Kusnierz-Cabala Lubomir Skladany Ivica Grgurevic Małgorzata Wójcik-Bugajska Tomasz Grodzicki Dominika Stygar Tomasz Rogula |
author_facet |
Michał Kukla Tomasz Menżyk Marcin Dembiński Marek Winiarski Aleksander Garlicki Monika Bociąga-Jasik Magdalena Skonieczna Dorota Hudy Barbara Maziarz Beata Kusnierz-Cabala Lubomir Skladany Ivica Grgurevic Małgorzata Wójcik-Bugajska Tomasz Grodzicki Dominika Stygar Tomasz Rogula |
author_sort |
Michał Kukla |
title |
Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes |
title_short |
Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes |
title_full |
Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes |
title_fullStr |
Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes |
title_full_unstemmed |
Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes |
title_sort |
anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and sars-cov-2 outcomes |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/ab7ee6424fed4bea89e7d91ef4bfec76 |
work_keys_str_mv |
AT michałkukla antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT tomaszmenzyk antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT marcindembinski antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT marekwiniarski antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT aleksandergarlicki antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT monikabociagajasik antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT magdalenaskonieczna antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT dorotahudy antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT barbaramaziarz antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT beatakusnierzcabala antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT lubomirskladany antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT ivicagrgurevic antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT małgorzatawojcikbugajska antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT tomaszgrodzicki antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT dominikastygar antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes AT tomaszrogula antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes |
_version_ |
1718442651653505024 |